tirzepatide w with Glycine + B12 Most Successful Weight Loss Program. Tirzepatide (Month 1) 2.5mg |

Tirzepatide is a dual GIP/GLP-1 receptor agonist

If positive, approval could follow within 18-24 months

59 Nevertheless, whether a GLP-1R agonist/GIPR antagonist can improve T2DM needs more evidences

Although tirzepatide was first licensed for diabetes, you dont have to be diabetic to receive tirzepatide (Mounjaro) for weight loss

Best for: People who want to avoid injections entirely, or those looking for a convenient daily oral alternative with competitive weight loss results

Their blood sugar effects are substantial: Semaglutide: Reduces A1c by 1.5-1.8% from baseline (Ozempic trials) Tirzepatide: Reduces A1c by 2.0-2.3% from baseline (SURPASS trials)